A study in mouse models of multiple sclerosis demonstrates a compound called sobetirome promotes remyelination, and a derivative of the compound can penetrate the blood-brain barrier to enable a tenfold increase in infiltration to the CNS. Researchers are confident their research will translate from mice into humans, providing a new avenue of treatment for MS.![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v_BWIHexf--ceTodXeYDbvsdtsl_k7UvKeTEIdSNKmC8k5irrrh0-Ey7bP8KJbrJb9mOg3pqmc6GYH95JLh9QLLuUDAUy6E_eS3btuZBwLeZeo5qbKkxIYGTXGKAG-5CAtcHyNmJ7tVb5DsVGu5RyErM7UMOEeeLo=s0-d)
from Neuroscience News Updates http://bit.ly/2ZjunW6
from Neuroscience News Updates http://bit.ly/2ZjunW6
Comments
Post a Comment